There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
1-Methyl-Inosine is a modified nucleoside which is present in higher concentrations in the urinary excretion of patients afflicted with breast cancer. It acts a a biomarker for diagnosis of the disease.
Purity by HPLC
Not less than 90 %
Hazard Compound
Refer MSDS for accurate information.
Overview
1-Methyl-Inosine is a modified nucleoside which is present in higher concentrations in the urinary excretion of patients afflicted with breast cancer. It acts a a biomarker for diagnosis of the disease.
![N-[2-(1-benzylpiperidin-2-yl)ethyl]-2-(3,6-dioxo-1,2,3,6-tetrahydropyridazin-4-yl)acetamide](https://structures.clearsynth.com/CS-O-63944.PNG)
